Abstract 1779: Anti-Müllerian hormone type II receptor (AMHRII), a cancer target for GM103, a novel antibody-drug conjugate (ADC)
Dubreuil, Olivier, Barret, Jean-Marc M., Mohan, Raghav, Pugnière, Martine, Pepin, David, Desigaud, Delphine, McDowell, William, Manin, Anaïs, Camper, Nicolas, Nicolas, André, Donahoe, Patricia K., Prost, Jean-François F.
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract 774: Anti-Müllerian hormone type II receptor (AMHRII) found expressed in human non-gynecological solid tumors, suggesting potential broader applications for anti-AMHRII-based therapy
Barret, Jean-Marc M., Meseure, Didier, Bataillon, Guillaume, Andersson, Noora, Auguste, Aurélie, Dubreuil, Olivier, Färkkilä, Anniina, Perrial, Emeline, Bossard, Celine, Loison, Emily, Jarry, Anne, Nicolas, André, Lemée, Fanny, Gaillard, Solenne, Lahmar, Mehdi, Anttonen, Mikko, Champenois, Gabriel, Dumontet, Charles, Ray-Coquard, Isabelle, Leary, Alexandra, Tabah-Fisch, Isabelle, Vincent-Salomon, Anne, Prost, Jean-François F.
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Electrophysiological effects of S 16257, a novel sino‐atrial node modulator, on rabbit and guinea‐pig cardiac preparations: comparison with UL‐FS 49
Thollon, Catherine, Cambarrat, Christine, Vian, Joël, Prost, Jean‐François, Peglion, Jean Louis, Vilaine, Jean Paul
Published in British journal of pharmacology (01.05.1994)
Published in British journal of pharmacology (01.05.1994)
Get full text
Journal Article